However, its limitations include a lack of characterization of i:cFGF23 in non-healthy individuals, such as those with chronic kidney disease, and the heterogeneous units utilized for C-terminal FGF23, which necessitates a semi-quantitative approach for interpreting the i:cFGF23 ratio.44 The gene discussed is FGF23; the disease is chronic kidney disease.